IL10 and urothelial carcinoma: IFN-α2b is thought to increase the response of Th1 cell caused by BCG instillation through multiple approaches such as inhibiting interleukin-10 and enhance tumor necrosis factor-related apoptosis-inducing ligand release, ultimately lead to the suppression and subsequent destruction of urothelial carcinoma [44,45].